288 related articles for article (PubMed ID: 8878385)
1. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.
Kershner RP; Fitzsimmons WE
Transplantation; 1996 Oct; 62(7):920-6. PubMed ID: 8878385
[TBL] [Abstract][Full Text] [Related]
2. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
Hedayat S; Kershner RP; Su G
J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
[TBL] [Abstract][Full Text] [Related]
3. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.
Laskow DA; Vincenti F; Neylan JF; Mendez R; Matas AJ
Transplantation; 1996 Oct; 62(7):900-5. PubMed ID: 8878381
[TBL] [Abstract][Full Text] [Related]
4. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
[TBL] [Abstract][Full Text] [Related]
7. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
Venkataramanan R; Shaw LM; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons WE; Virji M; Jain A; Brayman KL; Shaked A
J Clin Pharmacol; 2001 May; 41(5):542-51. PubMed ID: 11361051
[TBL] [Abstract][Full Text] [Related]
10. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
12. A multicenter trial of FK506 as rescue therapy for renal transplant recipients in Taiwan.
Shu KH; Cheng CH; Wu MJ; Lian JD; Huang CC; Chu SH; Chiang YJ; Lai MK; Lee PH
Transplant Proc; 1998 Nov; 30(7):3584-6. PubMed ID: 9838570
[No Abstract] [Full Text] [Related]
13. FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects.
Bäckman L; Nicar M; Levy M; Distant D; Eisenstein C; Renard T; Goldstein R; Husberg B; Gonwa TA; Klintmalm G
Transplantation; 1994 Feb; 57(4):519-25. PubMed ID: 7509516
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
15. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
17. Tacrolimus: immunosuppression following liver and kidney transplant.
Clark W
J Clin Pharm Ther; 1996 Jun; 21(3):135-41. PubMed ID: 8873845
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
[TBL] [Abstract][Full Text] [Related]
19. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
20. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
